Mitogen-activated protein kinase-dependent interleukin-1β intracrine signaling is modulated by yopp during yersinia enterocolitica infection

Infection and Immunity

Volumn 80, Issue 1, 2012, Pages 289-297

  Bose, Rumu ^a   Thinwa, Josephine ^a   Chaparro, Paola ^a   Zhong, Youmin ^a   Bose, Santanu ^a   Zhong, Guangming ^a   Dube, Peter H ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1ALPHA; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE; BACTERIAL PROTEIN; VIRULENCE FACTOR; YOPP PROTEIN, YERSINIA;

ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME INHIBITION; EPITHELIUM CELL; FEMALE; HELA CELL; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; INTRACELLULAR SIGNALING; INTRACRINE SIGNALING; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SUPERNATANT; WILD TYPE; YERSINIA ENTEROCOLITICA; YERSINIOSIS; ACTIVE TRANSPORT; BIOSYNTHESIS; CHEMISTRY; CYTOPLASM; DOWN REGULATION; DRUG ANTAGONISM; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PATHOGENICITY; SIGNAL TRANSDUCTION;

ACTIVE TRANSPORT, CELL NUCLEUS; BACTERIAL PROTEINS; CELL NUCLEUS; CYTOPLASM; DOWN-REGULATION; EPITHELIAL CELLS; HELA CELLS; HUMANS; INTERLEUKIN-1ALPHA; INTERLEUKIN-8; MITOGEN-ACTIVATED PROTEIN KINASES; SIGNAL TRANSDUCTION; VIRULENCE FACTORS; YERSINIA ENTEROCOLITICA;

EID: 84857075254     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.05742-11     Document Type: Article

References (41)

1. Autenrieth IB, Beer M, Bohn E, Kaufmann SHE, Heesemann J. 1994. Immune responses to Yersinia enterocolitica in susceptible BALB/c and resistant C57BL/6 mice: an essential role for gamma interferon. Infect. Immun. 62:2590-2599.
2. Autenrieth IB, Tingle A, Reske-Kunz A, Heesemann J. 1992. T lymphocytes mediate protection against Yersinia enterocolitica in mice: characterization of murine T-cell clones specific for Y. enterocolitica. Infect. Immun. 60:1140-1149.
3. Autenrieth IB, Vogel U, Preger S, Heymer B, Heesemann J. 1993. Experimental Yersinia enterocolitica infection in euthymic and T-celldeficient athymic nude C57BL/6 mice: comparison of time course, histomorphology, and immune response. Infect. Immun. 61:2585-2595.
4. Bergsbaken T, Cookson BT. 2007. Macrophage activation redirects yersinia-infected host cell death from apoptosis to caspase-1-dependent pyroptosis. PLoS Pathog. 3:e161.
5. Beuscher HU, Rausch U-P, Otterness IG, Röllinghoff M. 1992. Transition from interleukin 1β (IL-1β) to IL-1α production during maturation of inflammatory macrophages in vivo. J. Exp. Med. 175:1793-1797.
6. Beuscher HU, Rodel F, Forsberg A, Rollinghoff M. 1995. Bacterial evasion of the host immune defense: Yersinia enterocolitica encodes a suppressor for tumor necrosis factor alpha expression. Infect. Immun. 63: 1270-1277.
7. Bohn E, Heesemann J, Ehlers S, Autenrieth IB. 1994. Early gamma interferon mRNA expression is associated with resistance of mice against Yersinia enterocolitica. Infect. Immun. 62:3027-3032.
8. Bohn E, et al. 1998. IL-18 (IFN-gamma-inducing factor) regulates early cytokine production in, and promotes resolution of, bacterial infection in mice. J. Immunol. 160:299-307.
9. Boland A, Cornelis GR. 1998. Role of YopP in suppression of tumor necrosis factor alpha release by macrophages during Yersinia infection. Infect. Immun. 66:1878-1884.
10. Bose S, Kar N, Maitra R, DiDonato JA, Banerjee AK. 2003. Temporal activation of NF-kappaB regulates an interferon-independent innate antiviral response against cytoplasmic RNA viruses. Proc. Natl. Acad. Sci. U. S. A. 100:10890-10895.
11. Bottone EJ. 1983. Current trends of Yersinia enterocolitica isolates in the New York City area. J. Clin. Microbiol. 17:63- 67.
12. Bottone EJ. 1997. Yersinia enterocolitica: the charisma continues. Clin. Microbiol. Rev. 10:257-276.
13. Buryskova M, Pospisek M, Grothey A, Simmet T, Burysek L. 2004. Intracellular interleukin-1alpha functionally interacts with histone acetyltransferase complexes. J. Biol. Chem. 279:4017- 4026.
14. Carter PB. 1975. Oral Yersinia enterocolitica infection of mice. Am. J. Pathol. 81:703-705.
15. Carter PB, Collins FM. 1974. Experimental Yersinia enterocolitica infection in mice: kinetics of growth. Infect. Immun. 9:851- 857.
16. Carter PB, Collins FM. 1974. The route of enteric infection in normal mice. J. Exp. Med. 139:1189-1203.
17. Cheng W, et al. 2008. Intracellular interleukin-1alpha mediates interleukin-8 production induced by Chlamydia trachomatis infection via a mechanism independent of type I interleukin-1 receptor. Infect. Immun. 76:942-951.
18. Cornelis GR, Wolf-Watz H. 1997. The Yersinia Yop virulon: a bacterial system for subverting eukaryotic cells. Mol. Microbiol. 23:861- 867.
19. Dinarello, C. 1997. Interleukin-1. Cytokine Growth Factor Rev. 8:253-265.
20. Dube P. 2009. Interaction of Yersinia with the gut: mechanisms of pathogenesis and immune evasion. Curr. Top. Microbiol. Immunol. 337:61-91.
21. Dube PH, Handley SA, Lewis J, Miller VL. 2004. Protective role of interleukin-6 during Yersinia enterocolitica infection is mediated through the modulation of inflammatory cytokines. Infect. Immun. 72: 3561-3570.
22. Dube PH, Handley SA, Revell PA, Miller VL. 2003. The rovA mutant of Yersinia enterocolitica displays differential degrees of virulence depending on the route of infection. Infect. Immun. 71:3512-3520.
23. Dube PH, Revell PA, Chaplin DD, Lorenz RG, Miller VL. 2001. A role for IL-1 alpha in inducing pathologic inflammation during bacterial infection. Proc. Natl. Acad. Sci. U. S. A. 98:10880-10885.
24. Haller JC, Carlson S, Pederson KJ, Pierson DE. 2000. A chromosomally encoded type III secretion pathway in Yersinia enterocolitica is important in virulence. Mol. Microbiol. 36:1436-1446.
25. Handley SA, Dube PH, Miller VL. 2006. Histamine signaling through the H(2) receptor in the Peyer's patch is important for controlling Yersinia enterocolitica infection. Proc. Natl. Acad. Sci. U. S. A. 103:9268-9273.
26. Hu B, et al. 2003. A nuclear target for interleukin-1alpha: interaction with the growth suppressor necdin modulates proliferation and collagen expression. Proc. Natl. Acad. Sci. U. S. A. 100:10008-10013.
27. Isberg RR, Falkow S. 1985. A single genetic locus encoded by Yersinia pseudotuberculosis permits invasion of cultured animal cells by Escherichia coli K-12. Nature 317:262-264.
28. Kampik D, Schulte R, Autenrieth IB. 2000. Yersinia enterocolitica Invasin protein triggers differential production of interleukin-1, interleukin-8, monocyte chemoattractant protein 1, granulocyte-macrophage colony stimulating factor, and tumor necrosis factor alpha in epithelial cells: implications for understanding the early cytokine networks in Yersinia infections. Infect. Immun. 68:2484-2492.
29. Maier JA, Statuto M, Ragnotti G. 1994. Endogenous interleukin 1 alpha must be transported to the nucleus to exert its activity in human endothelial cells. Mol. Cell. Biol. 14:1845-1851.
30. McMahon GA, Garfinkel S, Prudovsky I, Hu X, Maciag T. 1997. Intracellular precursor interleukin (IL)-1alpha, but not mature IL-1alpha, is able to regulate human endothelial cell migration in vitro. J. Biol. Chem. 272:28202-28205.
31. Miller VL, Falkow S. 1988. Evidence for two genetic loci in Yersinia enterocolitica that can promote invasion of epithelial cells. Infect. Immun. 56:1242-1248.
32. Mills SD, et al. 1997. Yersinia enterocolitica induces apoptosis in macrophages by a process requiring functional type III secretion and translocation mechanisms and involving YopP, presumably acting as an effector protein. Proc. Natl. Acad. Sci. U. S. A. 94:12638-12643.
33. Mittal R, Peak-Chew SY, McMahon HT. 2006. Acetylation of MEK2 and I kappa B kinase (IKK) activation loop residues by YopJ inhibits signaling. Proc. Natl. Acad. Sci. U. S. A. 103:18574-18579.
34. Mukherjee S, et al. 2006. Yersinia YopJ acetylates and inhibits kinase activation by blocking phosphorylation. Science 312:1211-1214.
35. Palmer LE, Pancetti AR, Greenberg S, Bliska JB. 1999. YopJ of Yersinia spp. is sufficient to cause downregulation of multiple mitogen-activated protein kinases in eukaryotic cells. Infect. Immun. 67:708-716.
36. Trülzsch K, Sporleder T, Igwe EI, Russmann H, Heesemann J. 2004. Contribution of the major secreted yops of Yersinia enterocolitica O:8 to pathogenicity in the mouse infection model. Infect. Immun. 72: 5227-5234.
37. Werman A, et al. 2004. The precursor form of IL-1alpha is an intracrine proinflammatory activator of transcription. Proc. Natl. Acad. Sci. U. S. A. 101:2434-2439.
38. Wessendorf JH, Garfinkel S, Zhan X, Brown S, Maciag T. 1993. Identification of a nuclear localization sequence within the structure of the human interleukin-1 alpha precursor. J. Biol. Chem. 268:22100-22104.
39. Winzen R, et al. 1999. The p38 MAP kinase pathway signals for cytokineinduced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism. EMBO J. 18:4969-4980.
40. Young GM, Schmiel DH, Miller VL. 1999. A new pathway for the secretion of virulence factors by bacteria: the flagellar export apparatus functions as a protein-secretion system. Proc. Natl. Acad. Sci. U. S. A. 96: 6456-6461.
41. Yu HB, Finlay BB. 2008. The caspase-1 inflammasome: a pilot of innate immune responses. Cell Host Microbe 4:198-208.